Please use this identifier to cite or link to this item:
Title: Dual functions of gold nanorods as photothermal agent and autofluorescence enhancer to track cell death during plasmonic photothermal therapy
Authors: Kannadorai, Ravi Kumar
Chiew, Geraldine Giap Ying
Luo, Kathy Qian
Liu, Quan
Keywords: Photothermal therapy
Gold nanorods
Renal cell carcinoma
Issue Date: 2014
Source: Kannadorai, R. K., Chiew, G. G. Y., Luo, K. Q., & Liu, Q. (2014). Dual functions of gold nanorods as photothermal agent and autofluorescence enhancer to track cell death during plasmonic photothermal therapy. Cancer Letters, 357(1), 152-159.
Series/Report no.: Cancer Letters
Abstract: Gold nanorods have the potential to localize the treatment procedure by hyperthermia and influence the fluorescence. The longitudinal plasmon peak contributes to the photothermal effect by converting light to heat. When these nanorods are PEGylated, it not only makes it biocompatible but also acts as a spacer layer during fluorescence enhancement. When the PEGylated nanorods are internalized inside the cells through endocytosis, the transverse plasmonic peak combined with the enhanced absorption and scattering properties of the nanorods can enhance the autofluorescence emission intensity from the cell. The autofluorescence from the mitochondria inside cells which reflects the respiratory status of the cell was enhanced two times by the presence of nanorods within the cell. At four minutes, the nanorods incubated cells reached the hyperthermic temperature when illuminated continuously with near infrared laser. The cell viability test and autofluorescence intensity curve showed a similar trend indicating the progress of cell death over time. This is the first report to the best of our knowledge to suggest the potential of exploiting the dual capabilities of gold nanorods as photothermal agents and autofluorescence enhancer to track cell death.
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2014.11.022
Schools: School of Chemical and Biomedical Engineering 
Rights: © 2014 Elsevier. This is the author created version of a work that has been peer reviewed and accepted for publication by Cancer Letters, Elsevier. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [].
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Journal Articles

Citations 10

Updated on Jul 8, 2024

Web of ScienceTM
Citations 10

Updated on Oct 31, 2023

Page view(s) 10

Updated on Jul 13, 2024

Download(s) 20

Updated on Jul 13, 2024

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.